• ImmuneWatch secures a VLAIO grant to tailor their technology to vaccine developers

    Monday September 12th 2022

  • BioLizard is now an Official Illumina Connected Analytics Implementation Partner

    Monday September 5th 2022

  • NEXTSTELLIS® oral contraceptive now available in Australia

    Tuesday July 26th 2022

  • ImmuneWatch signs licence agreement with UAntwerp and UZA and officially becomes a university spin-off company

    Friday June 24th 2022

  • Pathomation announces CE-IVD mark for clinical diagnostic use of vendor neutral PMA.core software

    Tuesday May 31st 2022

  • Precirix strengthens patent portfolio of its precision radiopharmaceuticals platform

    Tuesday May 31st 2022

  • Belgian biotech in European Top-3 despite turbulent times

    Wednesday May 18th 2022

  • flanders.bio appoints CEO and COO in newly created role

    Wednesday May 18th 2022

  • Your news here?

  • Spearhead cluster flanders.healthTech turns into MEDVIA and is ready to make a change in healthcare innovation

    Tuesday May 17th 2022

  • QbD Group requalifies as Best Managed Company

    Friday May 13th 2022

  • Augustine Therapeutics appoints Gerhard Koenig as Chairman of the Board, forms Clinical Advisory Board, and broadens therapeutic indications

    Tuesday May 10th 2022

Strategic Partners